[Federal Register Volume 64, Number 25 (Monday, February 8, 1999)]
[Notices]
[Pages 6093-6099]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-2905]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention
[Program Announcement 99033]


State and Local Childhood Lead Poisoning Prevention Programs; 
Notice of Availability of Funds

A. Purpose

    The Centers for Disease Control and Prevention (CDC) announces the 
availability of fiscal year (FY) 1999 funds for new and competing 
continuation state and local programs to develop and improve childhood 
lead poisoning prevention activities and build statewide capacity to 
conduct surveillance of blood lead levels in children. This 
announcement is related

[[Page 6094]]

to the priority area of Environmental Health.
    This grant program is to provide the impetus for the development, 
implementation, expansion, and evaluation of state and local childhood 
lead poisoning prevention programs which include statewide surveillance 
capacity to determine areas at high risk for lead exposure. In 
particular, this grant program is to carry out the core public health 
functions in childhood lead poisoning prevention programs (CLPPP). More 
specifically, this grant program is to bring about: (1) Screening of 
children who are potentially exposed to lead and follow-up care for 
children who are identified with elevated blood lead levels (BLLs); (2) 
awareness and action among the general public and affected 
professionals in relation to preventing childhood lead poisoning; and 
(3) primary prevention of childhood lead poisoning in high-risk areas 
in collaboration with other government and community-based 
organizations. As State and local programs shift emphasis from 
providing direct screening and follow-up services to the core public 
health functions, grant funds may be used to support and emphasize 
health department responsibilities in screening and follow-up services 
of children at risk for lead poisoning. This includes improving 
coalitions and partnerships, conducting better and more sophisticated 
assessments, developing and evaluating policies and program performance 
and effectiveness based on established goals and objectives.

B. Eligible Applicants

    Applicant eligibility is divided into Parts A (New Applicants), B 
(Competing Continuation), and C (Alternative Surveillance Assessment) 
defined as follows:
    1. Part A applies to State and local health departments or other 
State and local health agencies or departments not currently funded by 
CDC.
    a. Also eligible are agencies or units of local government that 
serve jurisdictional populations greater than 500,000. In addition, 
eligible applicants include health departments or other official 
organizational authority (agency or instrumentality) of the District of 
Columbia, the Commonwealth of Puerto Rico, any territory or possession 
of the United States, and all Indian tribes.
    b. Applicants for local CLPP program grants from eligible units of 
local jurisdictions must either apply directly to CDC or apply as part 
of a statewide grant application. Local jurisdictions cannot submit 
applications directly to CDC and also apply as part of a statewide 
grant application.
    c. Applicants encouraged to apply under Part A include, but are not 
limited to; Arkansas, Georgia, Idaho, Kansas, Mississippi, Nevada, 
North Dakota, South Dakota, Tennessee, and Kentucky.
    2. Part B applies to applicants currently funded by Centers for 
Disease Control and Prevention whose project period is expiring in 
1999. Part B applicants are as follows: Colorado; Connecticut; 
Illinois; Jefferson County, Kentucky; Maryland; Minnesota; Nebraska; 
New York; Utah; Washington, D.C.; and Wisconsin.
    3. Part C applies to: (1) Applicants who apply under Part B, 
however funding will only be considered if their Part B application is 
successful and chosen for funding and, (2) applicants currently holding 
funded CDC Childhood Lead Poisoning Prevention Program and Childhood 
Blood Lead Surveillance grants that successfully report data to CDC's 
national surveillance database as of March 31st.

Additional Information for All State Applicants

    If a State agency applying for grant funds is other than the 
official State health department, written concurrence by the State 
health department must be provided.

C. Availability of Funds

Part A: New Applicants

    Up to $3,000,000 will be available in FY 1999 to fund up to 5 new 
grants. CDC anticipates that awards for the first budget year will 
range from $75,000 to $800,000.

Part B: Competing Continuations

    Up to $7,700,000 will be available in FY 1999 to fund up to 11 
competing continuation grants. CDC anticipates that awards for the 
first budget year will range from $75,000 to $1,500,000.

Part C: Alternative Surveillance Assessments

    Up to $400,000 will be available in FY 1999 to fund up to 4 
supplemental awards to support the development of alternative 
surveillance assessments. Alternative surveillance assessment awards 
are expected to range from $85,000 to $100,000, with the average award 
being approximately $95,000.

Awards for State Applicants

    To determine the suggested level of funding for which an individual 
State applicant for Part A or Part B is eligible, State applicants 
should refer to the table entitled ``State CLPPP's Only: Suggested 
Funding Categories Based on Projected Level of Effort Required to 
Provide Prevention and Surveillance activities to a State Population'' 
(included in the application package). Applicants are encouraged to use 
the funding category that is suggested for the applicant's State; 
however, note these are suggested funding guidelines and should not be 
regarded as absolute funding limits.

Awards for Local Applicants

    The suggested range of awards for local applicants is $250,000 to 
$800,000.

Additional Information on Funding for All Applicants for Part A, 
Part B and Part C

    New awards are expected to begin on or about July 1, 1999, and are 
made for 12-month budget periods within project periods not to exceed 3 
years. Estimates outlined above are subject to change based on the 
actual availability of funds and the scope and quality of applications 
received. Continuation awards within the project period will be made on 
the basis of satisfactory progress and availability of funds. Grant 
awards cannot supplant existing funding for CLPP or Alternative 
Surveillance programs. Grant funds should be used to enhance the level 
of expenditures from State, local, and other funding sources. Awards 
made under Parts A and B will be made with the expectation that program 
activities will continue when grant funds are terminated.

    Note:
    1. Grant funds may not be expended for medical care and 
treatment or for environmental remediation of sources of lead 
exposure. However, the applicant must provide a plan to ensure that 
these program activities are carried out.
    2. Not more than 10 percent (exclusive of Direct Assistance) of 
any grant or contract through the grant may be obligated for 
administrative costs. This 10 percent limitation is in lieu of, and 
replaces, the indirect cost rate.

D. Program Requirements

Part A and Part B: New and Competing Continuations

    The following are requirements for CLPP Programs:
    1. A director/manager with authority and responsibility to carry 
out the requirements of the program and/or a full time coordinator for 
surveillance activities.
    2. Provide qualified staff, other resources, and knowledge to 
implement the provisions of the program. Applicants requesting grant 
supported positions must provide assurances that such positions will be 
authorized to be filled by the applicant's personnel system.

[[Page 6095]]

    3. For State applicants, develop a statewide surveillance system in 
accordance with CDC guidance and submit data annually to CDC. Revise, 
refine, and carry out the proposed surveillance methodology. For local 
applicants, develop a data-management system that links with the 
State's surveillance system or develop an automated data-management 
system to collect and maintain laboratory data on the results of blood 
lead analyses and data on follow-up care for children with elevated 
BLLs. For both State and local applicants, use these systems to monitor 
timeliness and completeness of screening of high-risk children and of 
follow-up care for children with elevated BLLs.
    4. For State applicants, commitment to develop and implement a 
statewide childhood blood lead screening plan consistent with CDC 
guidance provided in Screening Young Children for Lead Poisoning: 
Guidance for State and Local Public Health Officials. For local 
applicants, commitment to participate in the statewide planning 
process.
    5. Establish effective, well-defined working relationships within 
public health agencies and with other agencies and organizations at 
national, State, and community levels (e.g.: Housing authorities; 
environmental agencies; maternal and child health programs; State 
Medicaid Early Periodic Screening, Diagnosis, and Treatment (EPSDT) 
programs; community and migrant health centers; community-based 
organizations providing health and social services in or near public 
housing units, as authorized under section 340A of the Public Health 
Service (PHS) Act; State and local epidemiology programs; State and 
local housing rehabilitation programs; schools of public health and 
medical schools; and environmental interest groups).
    6. Written assurance that income earned by the CLPP program will be 
returned to the program for its use.
    7. For State CLPP Programs, provide managerial, technical, 
analytical, and program evaluation assistance to local agencies and 
organizations in developing or strengthening their CLPP programs.
    8. Establish a system to monitor the notification and follow-up of 
children who are confirmed with elevated BLLs and who are referred for 
environmental services.
    9. SPECIAL REQUIREMENT regarding Medicaid provider-status of 
applicants: Pursuant to section 317A of the Public Health Service Act 
(42 U.S.C. 247b-1), as amended by Sec. 303 of the ``Preventive Health 
Amendments of 1992'' (Pub. L. 102-531), applicants AND current grantees 
must meet the following requirements: For CLPP program services which 
are Medicaid-reimbursable in the applicant's State:
    a. Applicants who directly provide these services must be enrolled 
with their state Medicaid agency as Medicaid providers.
    b. Providers who enter into agreements with the applicant to 
provide such services must be enrolled with their state Medicaid agency 
as providers. An exception to this requirement will be made for 
providers whose services are provided free of charge and who accept no 
reimbursement from any third-party payer. Such providers who accept 
voluntary donations may still be exempted from this requirement.

Part C: Alternative Surveillance Assessments

    The following are requirements for Alternative Surveillance 
Assessments:
    1. A coordinator in collaboration with the principal investigator 
with authority and responsibility to carry out the requirements of the 
assessment activities.
    2. Develop and implement a study protocol to include the following: 
Methodology, sample selection, field operation, and statistical 
analysis. Applicants must provide a means of assuring that the results 
of the study will be published.
    3. Revise, refine, and carry out the proposed methodology for 
conducting Alternative Surveillance Assessments.
    4. Monitor and evaluate all aspects of the assessment activities.
    5. Conduct and evaluate public health programs or have access to 
professionals who are knowledgeable in conducting such activities.

E. Application Content

    Use the information in the Program Requirements, Other 
Requirements, and Evaluation Criteria sections to develop the 
application content. Your application will be evaluated on the criteria 
listed, so it is important to follow them in laying out your program 
plan:
    1. Applications must be developed in accordance with PHS Form 5161-
1.
    2. Part B applicants also competing for Part C funds must submit a 
separate application.
    3. Application pages must be clearly numbered, and a complete index 
to the application and its appendices must be included.
    4. The original and two copies of the application set must be 
submitted UNSTAPLED and UNBOUND. All material must be typewritten, 
double spaced, printed on one side only, with un-reduced font (10 or 12 
point font only) on 8\1/2\'' by 11'' paper, and at least 1'' margins 
and heading and footers. All graphics, maps, overlays, etc., should be 
in black and white and meet the above criteria.
    5. A one-page, single-spaced, typed abstract must be submitted with 
the application. The heading should include the title of the grant 
program, project title, organization, name and address, project 
director, telephone number, facsimile number, and e-mail address.
    6. The main body of the CLPP program application must include the 
following understanding the problem, surveillance or data-management 
activities, statewide/jurisdiction-wide planning and collaboration, 
core public health functions, goals and objectives, program management 
and staffing, and program evaluation. The main body of the alternative 
surveillance assessments application must include the following study 
protocol, project personnel, and project management. Each should not 
exceed 75 pages. The abstract, budget narrative, and budget 
justification pages are not included in the 75 page limit. Supplemental 
information may be placed in appendices and should not exceed 25 pages.
    7. Part B applicants must submit a progress report no longer than 
10 pages.

F. Application

    Applicants must submit the original and two copies of the PHS 5161-
1 (OMB Number 0937-0189) on or before April 7, 1999. Submit the 
application to: Mattie B. Jackson, Grants Management Specialist, Grants 
Management Branch, Procurement and Grants Office Announcement 99033, 
Centers for Disease Control and Prevention (CDC), 2920 Brandywine Road, 
MS-E13, Atlanta, GA 30341
    Applications shall be considered as meeting the deadline if they 
are either: (1) Received on or before the deadline date, or (2) sent on 
or before the deadline date and received in time for submission for the 
review process. Applicants must request a legibly dated receipt from a 
commercial carrier or U.S. Postal Service. Private metered postmarks 
shall not be acceptable as proof of timely mailing.
    Applications which do not meet the criteria above are considered 
late applications. Late applications will not be considered in the 
current competition and will be returned to the applicant.

[[Page 6096]]

G. Evaluation Criteria

    The review of applications will be conducted by an independent 
review committee approved by CDC as they relate to the applicant's 
response to either Part A, Part B, or Part C. Applications will be 
reviewed for the quality, strength and completeness of the plan against 
the following criteria. The maximum rating score of an application is 
100 points.

Part A: New Applicants

1. Understanding of the Problem (15 points)
    The applicant's description and understanding of the burden and 
distribution of childhood lead exposure or elevated BLLs in their 
jurisdiction, using evidence (as available) of incidence and/or 
prevalence and demographic indicators. Specifically include a 
description of the prevalence of elevated blood lead levels in the 
Medicaid population. The extent to which the applicant reflects an 
understanding of prevention activities, including need, available 
resources, gaps, and use of this award to address gaps.
2. Surveillance Activity (20 points)
    For State Applicants: The applicant's description of plans to 
develop a childhood blood lead surveillance system that includes 
tracking lead screening services to children, especially Medicaid 
children and reports data annually to the CDC's national surveillance 
database. The clarity, feasibility, and scientific soundness of the 
surveillance approach. Also, the extent to which the proposed time 
table for accomplishing each activity and methods for evaluating each 
activity are appropriate and clearly defined. The following elements 
will be specifically evaluated:
    a. How laboratories report BLLs.
    b. How data will be collected and managed.
    c. How quality of data and completeness of reporting will be 
ensured.
    d. How and when data will be analyzed.
    e. How summary data will be reported and disseminated.
    f. Protocols for follow-up of individuals with elevated BLLs.
    g. Provisions to obtain denominator data (results of all laboratory 
blood lead tests, regardless of level).
    h. Time line and methods for evaluating Childhood Blood Lead 
Surveillance (CBLS) approach.
    For Local Applicants: The applicant's description of plans to 
develop a data management system, including the approach to participate 
in the State CBLS, where applicable. The clarity, feasibility, and 
scientific soundness of the approach to data management. Also, the 
extent to which a proposed schedule for accomplishing each activity and 
method for evaluating each activity are clearly defined and 
appropriate. The following elements will be specifically evaluated:
    a. How laboratory reports will be received.
    b. How data will be collected and managed.
    c. How quality of data and completeness of reporting will be 
assured.
    d. How and when data will be analyzed.
    e. How summary data will be reported and disseminated.
    f. Protocols for follow-up of individuals with elevated BLLs.
    g. Provisions to obtain denominator data (results of all laboratory 
blood lead tests, regardless of level).
    h. Time line and methods for evaluating data-collection approach.
3. Statewide/Jurisdiction-wide Planning and Collaboration (20 points)
    Applicants should describe a planning process to develop statewide/
jurisdiction-wide screening recommendations with appropriate local 
strategies. The following elements will be specifically evaluated:
    a. The proposed approach to developing and carrying out an 
inclusive state- or jurisdiction-wide screening plan as outlined in 
Screening Young Children for Lead Poisoning: Guidance for State and 
Local Health Officials.
    b. The extent to which the applicant plans to utilize surveillance 
and program data to produce a statewide/jurisdiction-wide screening 
recommendation, with specific attention given to the Medicaid 
population.
    c. Description of how collaborations are expected to facilitate the 
development of a screening plan and strengthen childhood lead poisoning 
prevention strategies.
    d. Evidence of collaboration with principal partners, including 
managed-care organizations, state Medicaid agency, child health-care 
providers and provider groups, insurers, community-based organizations, 
housing agencies, and banking, real-estate, and property-owner 
interests, must be demonstrated by letters of support, memoranda of 
understanding, contracts, or other documented evidence of relationships 
with important collaborators.
4. Capacity To Carry Out Public-health Core Functions (15 points)
    The description of the approach and activities necessary to achieve 
a balance among health-department roles in CLPP, including assessment, 
program and policy development, and monitoring, evaluating, and 
ensuring the provision of all necessary components of a comprehensive 
CLPP. Specifically, include a description of the capacity in place or 
plans to address:
    a. Epidemiologic structure to perform assessment of lead exposure 
and program response.
    c. Health education and communication strategies designed to reach 
actual and potential collaborators and partners and achieve program 
goals.
    d. Gaps in service provision, where gaps have been demonstrated.
    e. Evaluation approaches to examine basic data on CLPP burden and 
program activities and make course corrections.
5. Goals and Objectives (10 points)
    The extent to which the applicant's goals and objectives relate to 
the six (6) components of a comprehensive CLPP program. Objectives must 
be relevant, specific, measurable, achievable, and time-framed. There 
must be a formal work plan with a description of methods, a timetable 
for accomplishment of each objective, and the evaluation of each 
proposed objective.
6. Project Management and Staffing (10 points)
    The extent to which the applicant has the skills and ability to 
develop and carry out a comprehensive CLLP program. Specifically the 
applicant should:
    a. Describe the proposed health department staff roles in CLPP, 
their specific responsibilities, and their level of effort and time. 
Include a plan to expedite filling of all positions and assure that 
requested positions have been or will be approved by applicant's 
personnel system.
    b. Describe the plan to provide training and technical assistance 
to health department personnel and consultation to collaborators 
outside the health department, including proposed design of 
information-sharing systems.
7. Program Evaluation (10 points)
    The extent to which the applicant proposes to measure the overall 
impact of health department CLPP activities. Specific criteria should 
include:
    a. The plan for evaluating the impact or outcome of CLPP 
activities, including evaluation design, methods, and activities.

[[Page 6097]]

    b. Description of how the project will assess changes in public 
policy and measure the effectiveness of collaborative activities.
    c. Progress made in childhood lead poisoning prevention which 
resulted from planned health department strategies.
8. Budget Justification (not scored)
    Evaluation will be based on the extent to which the budget is 
reasonable, clearly justified, and consistent with the intended use of 
funds.

Part B: Competing Continuations

1. Understanding of the Problem (15 points)
    The applicant's description and understanding of the burden and 
distribution of childhood lead exposure or elevated BLLs in the 
jurisdiction, using evidence of incidence and/or prevalence and 
demographic indicators. Specifically include a description of the 
prevalence of elevated blood lead levels in the Medicaid population. 
The extent to which the applicant reflects an understanding of 
prevention activities, including need, available resources, gaps, and 
use of this award to address gaps.
2. Surveillance Activity (20 points)
    For State Applicants: The applicant's description of plans to 
expand their childhood blood lead surveillance system that includes 
tracking lead screening for Medicaid children, evaluate the existing 
system, and report data to the CDC's national surveillance database. 
The clarity, feasibility, and scientific soundness of the surveillance 
approach. Also, the extent to which the proposed time table for 
accomplishing each activity are appropriate and clearly defined. The 
following elements will be specifically evaluated:
    a. How laboratories report BLLs.
    b. How data will be collected and managed.
    c. How quality of data and completeness of reporting will be 
ensured.
    d. How and when data will be analyzed.
    e. How summary data will be reported and disseminated.
    f. Protocols for follow-up of individuals with elevated BLLs.
    g. Provisions to obtain denominator data (results of all laboratory 
blood lead tests, regardless of level).
    h. Time line and methods for evaluating Childhood Blood Lead 
Surveillance (CBLS) approach.
    For local applicants: The applicant's description of plans to 
expand their data management system, including the approach to 
participating in the state CBLS, where applicable. The clarity, 
feasibility, and scientific soundness of the approach to data 
management. Also, the extent to which the proposed schedule for 
accomplishing each activity and method for evaluating each activity are 
clearly defined and appropriate. The following elements will be 
specifically evaluated:
    a. How laboratory reports will be received.
    b. How data will be collected and managed.
    c. How quality of data and completeness of reporting will be 
assured.
    d. How and when data will be analyzed.
    e. How summary data will be reported and disseminated.
    f. Protocols for follow-up of individuals with elevated BLLs.
    g. Provisions to obtain denominator data (results of all laboratory 
blood lead tests, regardless of level).
    h. Time line and methods for evaluating data-collection approach.
3. Statewide/Jurisdiction-wide Planning and Collaboration (20 points)
    Applicants should describe the planning process that has been taken 
to develop statewide/jurisdiction-wide screening recommendations with 
appropriate local strategies. The following elements should be 
specifically evaluated:
    a. The approach to developing and carrying out an inclusive state- 
or jurisdiction-wide screening plan as outlined in Screening Young 
Children for Lead Poisoning: Guidance for State and Local Health 
Officials.
    b. The extent to which the applicant utilized surveillance and 
program data to produce statewide/jurisdiction-wide screening 
recommendations and target the Medicaid population.
    c. Description of how collaborations facilitated the development of 
a screening plan and strengthened childhood lead poisoning prevention 
strategies.
    d. Evidence of collaboration with principal partners, including 
managed-care organizations, state Medicaid agency, child health-care 
providers and provider groups, insurers, community-based organizations, 
housing agencies, and banking, real-estate, and property-owner 
interests, must be demonstrated by letters of support, memoranda of 
understanding, contracts, or other documented evidence of relationships 
with important collaborators.

    Note: For applicants under Part B, describe progress in 
developing and implementing the screening plan based upon each of 
the elements listed above.
4. Capacity To Carry Out Public-Health Core Functions (15 points)
    The description of the approach and activities taken to achieve a 
balance among health-department roles in CLPP, including assessment, 
program and policy development, and monitoring, evaluating, and 
ensuring the provision of all necessary components of a comprehensive 
CLPP. Specifically include a description of the steps that were taken 
to develop capacity to address:
    a. Epidemiologic structure to perform assessment of lead exposure 
and program response.
    b. Health education and communication strategies designed to reach 
actual and potential collaborators and partners and achieve program 
goals.
    c. Gaps in service provision where gaps have been demonstrated.
    d. Evaluation approaches to examine basic data on CLPP burden and 
program activities and make course corrections.
5. Goals and Objectives (10 points)
    The extent to which the applicant's goals and objectives relate to 
the six (6) components of a comprehensive CLPP program. Objectives must 
be relevant, specific, measurable, achievable, and time-framed. There 
must be a formal work plan with a description of methods and a 
timetable for accomplishment of each objective.
6. Project Management and Staffing (10 points)
    The extent to which the applicant has the skills and ability to 
develop and carry out a comprehensive CLLP program. Specifically the 
applicant should:
    a. Describe the proposed health department staff roles in CLPP, 
their specific responsibilities, and their level of effort and time. 
Include a plan to expedite filling of all positions and assure that 
requested positions have been or will be approved by the applicant's 
personnel system.
    b. Describe the plan to provide training and technical assistance 
to health department personnel and consultation to collaborators 
outside the health department, including proposed design of 
information-sharing systems.
7. Program Evaluation (10 points)
    The extent to which the applicant proposes to measure the overall 
impact of health department CLPP activities. Specific criteria should 
include:
    a. The plan for evaluating the impact and outcome of CLPP 
activities,

[[Page 6098]]

including the evaluation design, methods, and activities.
    b. Description of how the project will assess changes in the 
effectiveness of collaborative activities.
    c. Progress made in childhood lead poisoning prevention which 
resulted from planned health department strategies.
8. Budget Justification (not scored)
    Evaluation will be based on the extent to which the budget is 
reasonable, clearly justified, and consistent with the intended use of 
funds.

PART C: Alternative Surveillance Assessments--Factors to be Considered

1. Study Protocol (45 points)
    The protocol's scientific soundness (including adequate sample size 
with power calculations), quality, feasibility, consistency with 
project goals, and soundness of the evaluation plan (which should 
provide sufficient detail regarding the way in which the protocol will 
be implemented). The degree to which the applicant has met the CDC 
policy requirements regarding the inclusion of women, ethnic, and 
racial groups in the proposed project. This includes: (a) The proposed 
plan to include of both sexes and racial and ethnic minority 
populations for appropriate representation; (b) the proposed 
justification when representation is limited or absent; (c) a statement 
as to whether the design of the study is adequate to measure 
differences when warranted; and (d) a statement as to whether the plans 
for recruitment and outreach for study participants includes 
establishing partnerships with community-based agencies and 
organizations. Benefits of the partnerships should be described.
2. Project Personnel (20 points)
    The qualifications, experience (including experience in conducting 
relevant studies), and time commitment of the staff needed to carry out 
the study.
3. Project Management (35 points)
    The schedule for implementing and monitoring the proposed study 
also should be provided. The extent to which the application documents 
specific, attainable, and realistic goals and objectives, and describes 
the evaluation plan.
4. Budget Justification (not scored)
    The extent to which the budget is reasonable, clearly justified, 
and consistent with the intended use of cooperative agreement funds.
5. Human Subjects (not scored)
    The extent to which the applicant complies with the Department of 
Health and Human Services regulations (45 CFR part 46) on the 
protection of human subjects.

H. Other Requirements

Technical Reporting Requirements
    Provide CDC with the original plus two copies of:
    1. Quarterly progress reports which are required of all grantees. 
The quarterly report should not exceed 25 pages. Time lines for the 
quarterly reports will be established at the time of award, but are 
typically due 30 days after the end of each quarter.
    2. Calendar year surveillance data should be reported annually to 
CDC in the approved OMB format. Time lines for the annual report will 
be established at the time of award, however are typically due 90 days 
after the end of the year. Also submit a written surveillance report 
annually to CDC.
    3. Financial Status Reports, are due within 90 days of the end of 
the budget period.
    4. Final financial reports and performance reports are due within 
90 days after the end of the project period. Send all reports to: 
Mattie B. Jackson, Grants Management Specialist, Grants Management 
Branch, Procurement and Grants Office, Centers for Disease Control and 
Prevention (CDC), 2920 Brandywine Road, Mailstop E-13, Atlanta, GA 
30341
    5. Data collection initiated under this cooperative agreement 
program has been approved by the Office of Management and Budget under 
OMB number (0920-0337), ``National Childhood Blood Lead Surveillance 
System'', Expiration Date: March 31, 2000.
    The following additional requirements are applicable to this 
program. For a complete description of each, see Addendum 1 in the 
application kit.

AR-1  Human Subjects Requirement
AR-2  Requirements for Inclusion of Women and Racial and Ethnic 
Minorities in Research
AR-7  Executive Order 12372 Review
AR-9  Paperwork Reduction Act Requirements
AR-10  Smoke-Free Workplace Requirements
AR-11  Healthy People 2000
AR-12  Lobbying Restrictions

I. Authority

    This program is authorized under sections 301(a), 317A and 317B of 
the Public Health Service Act (42 U.S.C. 247(a), 247b-1, and 247b-3), 
as amended. Program regulations are set forth in Title 42, Code of 
Federal Regulations, part 51b. The Catalog of Federal Domestic 
Assistance number is 93.197.

J. Pre-Application Workshop for New and Competing Continuation 
Applicants

    1. A pre-application technical assistance workshop will be held to 
assist all prospective applicants in understanding CDC application 
requirements and program priorities. During the workshop, information 
will be presented on application and business management requirements, 
programmatic priorities, and other essential information for preparing 
applications.
    2. The workshop will be held Sunday, January 31, 1999 from, 2 p.m. 
to 5 p.m., prior to the annual CDC supported grantee meeting. 
Applicants interested in attending the workshop should make 
reservations at the Holiday Inn SunSpree Conference Center, Clearwater 
Beach, Florida, by calling 727-447-9566.
    In addition, for interested applicants, a telephone conference call 
for pre-application technical assistance will be held on Wednesday, 
February 17, 1999, from 1:30 p.m. to 3:30 p.m, Eastern Standard Time. 
The bridge number for the conference call is 1-800-311-3437, and the 
pass code is 669241. For further information about all workshops, 
please contact Claudette Grant-Joseph at 770-488-7330.

K. Where To Obtain Additional Information

    To receive additional written information, call 1-888-472-6874. You 
will be asked to leave your name, address, and phone number and will 
need to refer to Announcement 99033. You will receive a complete 
program description, information on application procedures, and 
application forms. CDC will not send application kits by facsimile or 
express mail. If you have questions after reviewing the contents of all 
documents, business management technical assistance may be obtained 
from:

Mattie B. Jackson, Grants Management Specialist, Grants Management 
Branch, Procurement and Grants Office, Centers for Disease Control and 
Prevention (CDC), 2920 Brandywine Road, Mailstop E-13, Atlanta, GA 
30341, telephone (404) 842-6564
Internet address [email protected]

    This and other CDC announcements are also available through the CDC

[[Page 6099]]

homepage on the Internet. The address for the CDC homepage is http://
www.cdc.gov.
    For programmatic technical assistance, contact:

Claudette A. Grant-Joseph, Chief, Program Services Section, Lead 
Poisoning Prevention Branch, Division of Environmental Hazards and 
Health Effects, National Center for Environmental Health, Centers for 
Disease Control and Prevention (CDC), 4770 Buford Highway, NE, Mailstop 
F-42, Atlanta, GA 30341-3724, telephone (770) 488-7330,
Internet address [email protected]

    Dated: February 2, 1999.
John L. Williams,
Director, Procurement and Grants Office, Centers for Disease Control 
and Prevention (CDC).
[FR Doc. 99-2905 Filed 2-5-99; 8:45 am]
BILLING CODE 4160-18-U